Mon, Jun 9, 2025
1- Department of Pathology, Clinical Sciences, California Northstate University, Elk Grove, CA, USA and Research Trainee, Ejyde International Education and Research Consultancy, USA , okikis@yahoo.com
2- Research Trainee, Ejyde International Education and Research Consultancy, USA
3- Department of Pathology, Eko University of Medicine and Health Sciences, Lagos, Nigeria
4- Director, Alluring Healthcare Solutions LLC, MD, USA
2- Research Trainee, Ejyde International Education and Research Consultancy, USA
3- Department of Pathology, Eko University of Medicine and Health Sciences, Lagos, Nigeria
4- Director, Alluring Healthcare Solutions LLC, MD, USA
Abstract: (241 Views)
In accordance with The American College of Obstetricians and Gynecologists (ACOG) guidelines, hypertensive disorders during pregnancy remain a prominent contributor to maternal and perinatal mortality on a global scale. Toxemia of pregnancy is estimated to complicate 2–8% of pregnancies worldwide. It is predominantly in Latin America and the Caribbean, where it accounts for 26% of maternal deaths. In Africa and Asia, hypertensive disorders contribute to 9% of maternal deaths. Despite lower maternal mortality rates in high-income countries, 16% of maternal deaths can be attributed to hypertensive disorders.
The pathogenesis of the disease remains incompletely understood, but it is believed to be because of an imbalance between pro- and antiangiogenic factors. The imbalances are related to numerous triggers, namely, extreme ages, typically below 14 or over the age of 35, personal and family history of chronic Hypertension, preeclampsia, or diabetes. Additional risk factors include being overweight, primigravida, multiparity, and race (high among Black or Hispanic ethnicity). Systolic blood pressure at randomization, pre-pregnancy weight, smoking history, and the number of previous abortions or miscarriages were found to be associated with pre-eclampsia. The review aims to discuss the pathogenesis of Toxemia of pregnancy concerning the roles of cytokines and chemokines.
The pathogenesis of the disease remains incompletely understood, but it is believed to be because of an imbalance between pro- and antiangiogenic factors. The imbalances are related to numerous triggers, namely, extreme ages, typically below 14 or over the age of 35, personal and family history of chronic Hypertension, preeclampsia, or diabetes. Additional risk factors include being overweight, primigravida, multiparity, and race (high among Black or Hispanic ethnicity). Systolic blood pressure at randomization, pre-pregnancy weight, smoking history, and the number of previous abortions or miscarriages were found to be associated with pre-eclampsia. The review aims to discuss the pathogenesis of Toxemia of pregnancy concerning the roles of cytokines and chemokines.
References
1. Dong C, Della-Morte D, Rundek T, Wright CB, Elkind MSV, Sacco RL. Evidence to Maintain the Systolic Blood Pressure Treatment Threshold at 140 mm Hg for Stroke Prevention. Hypertension. 2016;67(3):520-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Keelan JA, Mitchell MD. Placental cytokines and preeclampsia. Front Biosci. 2007;12(1):2706–27. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Boraschi D, Penton-Rol G, Amodu O, Blomberg MT. Women in Cytokines and Soluble Mediators in Immunity. Front Immunol. 2024:15:1395165. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiology. Cardiovasc J Afr. 2016;27(2):71-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Rana S, Lemoine E, Granger J, Karumanchi SA. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094-112. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Vadhera RB, Simon M. Hypertensive Emergencies in Pregnancy. Clin Obstet Gynecol. 2014;57(4):797-805. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Titus A, Marappa-Ganeshan R. Physiology, Endothelin (Internet). PubMed. Treasure Island (FL): StatPearls Publishing; 2020. Available from: [View at Publisher] [PMID] [Google Scholar]
8. Ahmad S, Ahmed A. Elevated Placental Soluble Vascular Endothelial Growth Factor Receptor-1 Inhibits Angiogenesis in Preeclampsia. Circulation Research. 2004;95(9):884-91. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Gohar EY, Pollock DM. Sex-Specific Contributions of Endothelin to Hypertension. 2018;20(7). [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Ioannis Bellos, Vasilios Karageorgiou, Dimitrios Kapnias, Konstantina-Eleni Karamanli, Charalampos Siristatidis he role of interleukins in Am J Reprod Immunol2018;80(6) [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Tranquilli AL, Landi B, Corradetti A, Giannubilo SR, Sartini D, Pozzi V, et al. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine. 2007;40(2):82-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview.Reprod Biomed Online. 2006;13(5):680-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Huang X; Huang H; Dong M; Yao Q; Wang H; "Serum and Placental Interleukin-18 Are Elevated in Preeclampsia." Reprod Immunoly. 2005 Feb;65(1):77-87. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. The Journal of Clinical Endocrinology & Metabolism. 1997;82(5):1582-8. [View at Publisher] [DOI] [Google Scholar]
15. Sakai M; Tsuda H; Tanabe K; Sasaki Y; Saito S; "Interleukin-12 Secretion by Peripheral Blood Mononuclear Cells Is Decreased in Normal Pregnant Subjects and Increased in Pre-eclamptic Patients." Am J Reprod Immunol.2002;47(2):91-7
. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Saito S; Umekage H; Sakamoto Y; Sakai M; Tanabe K; Sasaki ,et al. Increased T-Helper-1-Type Immunity and Decreased T-Helper-2-Type Immunity in Patients with Preeclampsia. Am J Reprod Immunol.1999;41(5):297-306. [View at Publisher] [DOI:10.1111/j.1600-0897.1999.tb00442.x] [PMID] [Google Scholar]
17. Huang S, Ana Claudia Zenclussen, Chen CP, Basar M, Yang H, Arcuri F. et al. The Implication of Aberrant GM-CSF Expression in Decidual Cells in the Pathogenesis of Preeclampsia. Am J Pathol. 2010 ;177(5):2472-82. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Preeclampsia." NHS Choices, NHS, www.nhs.uk/conditions/pre-eclampsia/. Accessed February 14, 2024. [Google Scholar]
19. Lockwood CJ, Matta P, Krikun G, Koopman LA, Masch R, Toti P, etal.Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia.Am J Pathol .2006;168(2):445-52. [View at Publisher] [DOI:10.2353/ajpath.2006.060185] [PMID] [Google Scholar]
20. Michel ML, Keller AC, Paget C, Fujio m,Trottein F,Savag pb, et al.Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia,Comparative Study, 2007; 14;204(5):995-1001. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Raghupathy R. Cytokines as Key Players in the Pathophysiology of Preeclampsia. Med Princ Pract . 2013;22(s1):8-19. [View at Publisher] [DOI:10.1159/000354200] [PMID] [Google Scholar]
22. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Ito M, Sakai M,T Shima, et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia,Clin Exp Immunol, 2007;149(1):139-45 [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Bellos I, Karageorgiou V, Kapnias D, Karamanli KE, Siristatidis C. The role of interleukins in pre-eclampsia: A comprehensive review. American Journal of Reproductive Immunology. 2018;80(6:13055. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Sharma A, Satyam A, Sharma JB.Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women,Am J Reprod Immunol 2007;58(1):21-30. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia,AmPathol,2004;164(3):1049-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with pree-eclampsia, Br J Obstet Gynaecol. 1995;102(1):20-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Presicce p, Cappelletti M, Senthamaraikannan p, Ma F, Morselli M, Jackson CM, et al. TNF-Signaling Modulates Neutrophil-Mediated Immunity at the Feto-Maternal Interface During LPS-Induced Intrauterine Inflammation,Front Immunol. 2020;11:558. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Benyo DF, Miles TM, Conrad KP. Hypoxia Stimulates Cytokine Production by Villous Explants from the Human Placenta,J Clin Endocrinol Metab, 1997;82(5):1582-8 [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Shahaway AA El, Elhady RR A, Abdelrhman AA, Yahia S. Role of maternal serum interleukin 17 in preeclampsia: diagnosis and prognosis. J Inflamm Res, 2019:12:175-180. [View at Publisher] [DOI:10.2147/JIR.S206800] [PMID] [Google Scholar]
30. Darmochwal-Kolarz Dorota, Michalak Magdalena, Kolarz Bogdan, Przegalinska-Kalamucka Monika, Bojarska-Junak Agnieszka, Sliwa Dariusz, et al. "The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency." BioMed Research International, 2017;2017(1):6904325. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Baharlou Rasoul, Atashzar Mohammad Reza, Ahmadi Vasmehjan Abbas, Rahimi Ebarahim, Khoshmirsafa Majid, Seif Farhad, et al. Reduced levels of T-helper 17-associated cytokines in the serum of patients with breast cancer: indicators for following the course of disease, Cent Eur J Immunol. 2016;41(1):78–85. [View at Publisher] [DOI:10.5114/ceji.2016.58819] [PMID] [Google Scholar]
32. Cubro H, Kashyap S, Nath MC, Ackerman AW, Garovic VD. The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.Curr Hypertens Rep. 2018;20(4):36. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Hashii K; Fujiwara H; Yoshioka S; Kataoka N; Yamada S; Hirano T;et al. "Peripheral Blood Mononuclear Cells Stimulate Progesterone Production by Luteal Cells Derived from Pregnant and Non-Pregnant Women: Possible Involvement of Interleukin-4 and Interleukin-10 in Corpus Luteum Function and Differentiation. Hum Reprod, 1998;13(1O):2738-44
. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. CHAIWORAPONGSA T, ROMERO R, GOMEZ-LOPEZ N, SUKSAI M, GALLO DM, JUNG E, etal. Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors, Am J Obstet Gynecol
. 2024 ;230(4):450.e1-450.e18 [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia.J Clin Invest, 1996;97(2):540-50. [View at Publisher] [DOI:10.1172/JCI118447] [PMID] [Google Scholar]
36. Próchnicka Katarzyna R, Felis-Giemza A, Olesińska m, Wojdasiewicz P, Paradowska-Gorycka A,Dariusz Szukiewicz, et al. "The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding,Int J Mol Sci. 2021;22(6):2922. [View at Publisher] [DOI:10.3390/ijms22062922] [PMID] [Google Scholar]
37. Mottola Michelle F. Components of Exercise Prescription and Pregnancy, Clin Obstet Gynecol,2016;59(3):552-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
38. Cameron MJ, Kelvin DJ. Cytokines, Chemokines and Their Receptors (Internet). Nih.gov. Landes Bioscience; 2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6294/ [View at Publisher] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.